{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:45:24Z","timestamp":1788273924581,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science and Technology Major Special Project for New Drug Development","award":["2018ZX09201016"],"award-info":[{"award-number":["2018ZX09201016"]}]},{"name":"National Science and Technology Major Special Project for Infectious Diseases","award":["2018ZX10302204"],"award-info":[{"award-number":["2018ZX10302204"]}]},{"DOI":"10.13039\/501100015850","name":"the Digestive Medical Coordinated Development Center of Beijing Hospitals Authority","doi-asserted-by":"crossref","award":["XXX 0104"],"award-info":[{"award-number":["XXX 0104"]}],"id":[{"id":"10.13039\/501100015850","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Hospitals Authority Incubating Program","award":["PX2019003"],"award-info":[{"award-number":["PX2019003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12072-019-09984-x","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T09:09:16Z","timestamp":1569402556000},"page":"788-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Epidemiology and clinical course of primary biliary cholangitis in the Asia\u2013Pacific region: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-4981","authenticated-orcid":false,"given":"Na","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-8890","authenticated-orcid":false,"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"9984_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.05.008","volume":"34\u201335","author":"A Tanaka","year":"2018","unstructured":"Tanaka A, Leung PSC, Gershwin ME. Evolution of our understanding of PBC. Best Pract Res Clin Gastroenterol  2018;34\u201335:3\u20139","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9984_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology  2009;50:291\u2013308","journal-title":"Hepatology"},{"key":"9984_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","volume":"11","author":"A Lleo","year":"2017","unstructured":"Lleo A, Marzorati S, Anaya JM, et al. Primary biliary cholangitis: a comprehensive overview. Hepatol Int  2017;11:485\u2013499","journal-title":"Hepatol Int"},{"key":"9984_CR4","first-page":"1165","volume":"113","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Takikawa H, Mochida S, et al. Changing nomenclature for PBC from \u201cPrimary Biliary Cirrhosis\u201d to \u201cPrimary Biliary Cholangitis\u201d. Nihon Shokakibyo Gakkai Zasshi  2016;113:1165\u20131167","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"9984_CR5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/EJA.0000000000000646","volume":"34","author":"LV Investigators","year":"2017","unstructured":"Investigators LV. Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS\u2014an observational study in 29 countries. Eur J Anaesthesiol  2017;34:492\u2013507","journal-title":"Eur J Anaesthesiol"},{"key":"9984_CR6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet  2015;386:1565\u20131575","journal-title":"Lancet"},{"issue":"1333\u20131341","key":"9984_CR7","first-page":"e6","volume":"16","author":"M Lu","year":"2018","unstructured":"Lu M, Li J, Haller IV, et al. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems. Clin Gastroenterol Hepatol  2018;16(1333\u20131341):e6","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9984_CR8","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/liv.12434","volume":"34","author":"K Boonstra","year":"2014","unstructured":"Boonstra K, Kunst AE, Stadhouders PH, et al. Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study. Liver Int  2014;34:e31\u2013e38","journal-title":"Liver Int"},{"key":"9984_CR9","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","volume":"50","author":"RP Myers","year":"2009","unstructured":"Myers RP, Shaheen AA, Fong A, et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology  2009;50:1884\u20131892","journal-title":"Hepatology"},{"key":"9984_CR10","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.9778\/cmajo.20180029","volume":"6","author":"EM Yoshida","year":"2018","unstructured":"Yoshida EM, Mason A, Peltekian KM, et al. Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study. CMAJ Open  2018;6:E664\u2013E670","journal-title":"CMAJ Open"},{"key":"9984_CR11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol  2012;56:1181\u20131188","journal-title":"J Hepatol"},{"key":"9984_CR12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","volume":"43","author":"KA Kim","year":"2016","unstructured":"Kim KA, Ki M, Choi HY, et al. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther  2016;43:154\u2013162","journal-title":"Aliment Pharmacol Ther"},{"key":"9984_CR13","doi-asserted-by":"crossref","unstructured":"Chen S, Duan W, Li M et al. Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: a single center follow-up study from China. J Gastroenterol Hepatol 2018","DOI":"10.1111\/jgh.14521"},{"key":"9984_CR14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.17235\/reed.2018.5533\/2018","volume":"110","author":"W Duan","year":"2018","unstructured":"Duan W, Ou X, Wang X, et al. Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA. Rev Esp Enferm Dig  2018;110:557\u2013563","journal-title":"Rev Esp Enferm Dig"},{"key":"9984_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/hepr.12242","volume":"44","author":"K Harada","year":"2014","unstructured":"Harada K, Nakanuma Y. Prevalence and risk factors of hepatocellular carcinoma in Japanese patients with primary biliary cirrhosis. Hepatol Res  2014;44:133\u2013140","journal-title":"Hepatol Res"},{"key":"9984_CR16","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s10620-011-1756-1","volume":"56","author":"C Hu","year":"2011","unstructured":"Hu C, Deng C, Song G, et al. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci  2011;56:3357\u20133363","journal-title":"Dig Dis Sci"},{"key":"9984_CR17","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","volume":"57","author":"K Harada","year":"2013","unstructured":"Harada K, Hirohara J, Ueno Y, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology  2013;57:1942\u20131949","journal-title":"Hepatology"},{"key":"9984_CR18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","volume":"127","author":"S Sood","year":"2004","unstructured":"Sood S, Gow PJ, Christie JM, et al. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology  2004;127:470\u2013475","journal-title":"Gastroenterology"},{"key":"9984_CR19","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ  2009;339:b2700","journal-title":"BMJ"},{"key":"9984_CR20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jclinepi.2010.04.014","volume":"63","author":"T Shamliyan","year":"2010","unstructured":"Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. J Clin Epidemiol  2010;63:1061\u20131070","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"9984_CR21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jclinepi.2010.08.006","volume":"64","author":"TA Shamliyan","year":"2011","unstructured":"Shamliyan TA, Kane RL, Ansari MT, et al. Development of quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists. J Clin Epidemiol  2011;64(6):637\u2013657","journal-title":"J Clin Epidemiol"},{"key":"9984_CR22","first-page":"927","volume":"36","author":"RG Watson","year":"1995","unstructured":"Watson RG, Angus PW, Dewar M, et al. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 1995;36:927\u2013930","journal-title":"Melbourne Liver Group. Gut"},{"issue":"1","key":"9984_CR23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jaut.1999.0299","volume":"13","author":"Keiji Tsuji","year":"1999","unstructured":"Tsuji K, Watanabe Y, Van De Water J, et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 1999;13:171\u2013178","journal-title":"Journal of Autoimmunity"},{"key":"9984_CR24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0895-4356(00)00370-X","volume":"54","author":"K Ohba","year":"2001","unstructured":"Ohba K, Omagari K, Kinoshita H, et al. Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan. J Clin Epidemiol  2001;54:845\u2013850","journal-title":"J Clin Epidemiol"},{"key":"9984_CR25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","volume":"127","author":"S Sood","year":"2004","unstructured":"Sood S, Gow PJ, Christie JM, et al. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology  2004;127:470\u2013475","journal-title":"Gastroenterology"},{"key":"9984_CR26","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1440-1746.2007.05048.x","volume":"22","author":"DN Amarapurkar","year":"2007","unstructured":"Amarapurkar DN, Patel ND. Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol  2007;22:2112\u20132117","journal-title":"J Gastroenterol Hepatol"},{"key":"9984_CR27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/MEG.0b013e3281ace0b7","volume":"19","author":"KT Fung","year":"2007","unstructured":"Fung KT, Fung J, Lai CL, et al. Etiologies of chronic liver diseases in Hong Kong. Eur J Gastroenterol Hepatol  2007;19:659\u2013664","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9984_CR28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1746.2007.05058.x","volume":"23","author":"RK Wong","year":"2008","unstructured":"Wong RK, Lim SG, Wee A, et al. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol  2008;23:599\u2013605","journal-title":"J Gastroenterol Hepatol"},{"key":"9984_CR29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2169\/internalmedicine.49.3169","volume":"49","author":"N Azemoto","year":"2010","unstructured":"Azemoto N, Abe M, Murata Y, et al. Clinical profile of primary biliary cirrhosis that was diagnosed as symptomatic primary biliary cirrhosis according to the revised diagnostic criteria in Japan. Intern Med  2010;49:1073\u20131038","journal-title":"Intern Med"},{"key":"9984_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-230X-10-100","volume":"10","author":"H Liu","year":"2010","unstructured":"Liu H, Liu Y, Wang L, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol  2010;10:100","journal-title":"BMC Gastroenterol"},{"key":"9984_CR31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12072-011-9329-0","volume":"6","author":"JH Ngu","year":"2012","unstructured":"Ngu JH, Gearry RB, Wright AJ, et al. Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study. Hepatol Int  2012;6:796\u2013800","journal-title":"Hepatol Int"},{"key":"9984_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","volume":"48","author":"G Rong","year":"2015","unstructured":"Rong G, Wang H, Bowlus CL, et al. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clin Rev Allergy Immunol  2015;48:132\u2013141","journal-title":"Clin Rev Allergy Immunol"},{"key":"9984_CR33","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3748\/wjg.v21.i12.3554","volume":"21","author":"XX Zhang","year":"2015","unstructured":"Zhang XX, Wang LF, Jin L, et al. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors. World J Gastroenterol  2015;21:3554\u20133563","journal-title":"World J Gastroenterol"},{"key":"9984_CR34","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","volume":"8","author":"KS Cheung","year":"2017","unstructured":"Cheung KS, Seto WK, Fung J, et al. Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: a Territory-Based Study in Hong Kong between 2000 and 2015. Clin Transl Gastroenterol  2017;8:e116","journal-title":"Clin Transl Gastroenterol"},{"key":"9984_CR35","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1038\/s41598-017-06807-7","volume":"7","author":"X Fan","year":"2017","unstructured":"Fan X, Wang T, Shen Y, et al. Underestimated male prevalence of primary biliary cholangitis in China: results of a 16-yr cohort study involving 769 patients. Sci Rep  2017;7:6560","journal-title":"Sci Rep"},{"key":"9984_CR36","doi-asserted-by":"crossref","unstructured":"Tanaka A, Mori M, Matsumoto K, et al. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res 2019","DOI":"10.1111\/hepr.13342"},{"key":"9984_CR37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhep.2001.26514","volume":"34","author":"H Miyakawa","year":"2001","unstructured":"Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology  2001;34:243\u2013248","journal-title":"Hepatology"},{"key":"9984_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.020","volume":"47","author":"A Floreani","year":"2018","unstructured":"Floreani A, Mangini C. Primary biliary cholangitis: old and novel therapy. Eur J Intern Med  2018;47:1\u20135","journal-title":"Eur J Intern Med"},{"key":"9984_CR39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","volume":"147","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, van Buuren HR, Hirschfield GM, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology  2014;147:1338\u20131349 (quiz e15)","journal-title":"Gastroenterology"},{"key":"9984_CR40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","volume":"50","author":"A Cavazza","year":"2009","unstructured":"Cavazza A, Caballeria L, Floreani A, et al. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology  2009;50:1162\u20131168","journal-title":"Hepatology"},{"key":"9984_CR41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"65","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Lammers WJ, van Buuren HR, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut  2016;65:321\u2013329","journal-title":"Gut"},{"key":"9984_CR42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ajg.2017.440","volume":"113","author":"MH Harms","year":"2018","unstructured":"Harms MH, Lammers WJ, Thorburn D, et al. Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome. Am J Gastroenterol  2018;113:254\u2013264","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"9984_CR43","first-page":"560-569.e7","volume":"144","author":"Marco Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 2013;144:560\u2013569 e7 (quiz e13\u20134)","journal-title":"Gastroenterology"},{"key":"9984_CR44","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/hep.22962","volume":"49","author":"AM Di Bisceglie","year":"2009","unstructured":"Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology 2009;49:S56\u2013S60","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-09984-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-019-09984-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-09984-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:12:16Z","timestamp":1600913536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-019-09984-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9984"],"URL":"https:\/\/doi.org\/10.1007\/s12072-019-09984-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"24 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Na Zeng, Weijia Duan, Sha Chen, Shanshan Wu, Hong Ma, Xiaojuan Ou, Hong You, Yuanyuan Kong and Jidong Jia declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any study with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}